BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.” The post Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus appeared first on The Daily Upside.| The Daily Upside